nybomycin has been researched along with kanamycin a in 1 studies
| Studies (nybomycin) | Trials (nybomycin) | Recent Studies (post-2010) (nybomycin) | Studies (kanamycin a) | Trials (kanamycin a) | Recent Studies (post-2010) (kanamycin a) |
|---|---|---|---|---|---|
| 12 | 0 | 7 | 7,169 | 187 | 946 |
| Protein | Taxonomy | nybomycin (IC50) | kanamycin a (IC50) |
|---|---|---|---|
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Escherichia coli K-12 | 6.8 | |
| Gap junction beta-2 protein | Homo sapiens (human) | 9.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Copley, GC; Elshahawi, SI; Hatcher, BE; Hower, JC; Kharel, MK; Liu, Y; Ponomareva, LV; Shaaban, KA; She, QB; Thorson, JS; Van Lanen, SG; Voss, SR; Wang, X; Ye, Q | 1 |
1 other study(ies) available for nybomycin and kanamycin a
| Article | Year |
|---|---|
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
Topics: Anti-Bacterial Agents; Antifungal Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Gram-Positive Bacteria; Humans; Molecular Structure; Quinolones; Spectrum Analysis; Streptomyces | 2019 |